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a
 
6
 
b
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Migration of Invasive Carcinoma Cells
 
Kathleen L. OÕConnor, Leslie M. Shaw, and Arthur M. Mercurio
 
Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215
 
Abstract. 
 
The 
 
a
 
6
 
b
 
4 integrin promotes carcinoma in-
vasion by its activation of a phosphoinositide 3-OH 
(PI3-K) signaling pathway (Shaw, L.M., I. Rabinovitz, 
H.H.-F. Wang, A. Toker, and A.M. Mercurio. 
 
Cell
 
. 91:
949—960). We demonstrate here using MDA-MB-435 
breast carcinoma cells that 
 
a
 
6
 
b
 
4 stimulates chemotactic 
migration, a key component of invasion, but that it has 
no influence on haptotaxis. Stimulation of chemotaxis 
by 
 
a
 
6
 
b
 
4 expression was observed in response to either 
lysophosphatidic acid (LPA) or fibroblast conditioned 
medium. Moreover, the LPA-dependent formation of 
lamellae in these cells is dependent upon 
 
a
 
6
 
b
 
4 expres-
sion. Both lamellae formation and chemotactic migra-
tion are inhibited or ÒgatedÓ by cAMP and our results 
reveal that a critical function of 
 
a
 
6
 
b
 
4 is to suppress the 
intracellular cAMP concentration by increasing the ac-
tivity of a rolipram-sensitive, cAMP-specific phospho-
diesterase (PDE). This PDE activity is essential for 
lamellae formation, chemotactic migration and inva-
sion based on data obtained with PDE inhibitors. Al-
though PI3-K and cAMP-specific PDE activities are 
both required to promote lamellae formation and 
chemotactic migration, our data indicate that they are 
components of distinct signaling pathways. The essence 
of our findings is that 
 
a
 
6
 
b
 
4 stimulates the chemotactic 
migration of carcinoma cells through its ability to influ-
ence key signaling events that underlie this critical com-
ponent of carcinoma invasion.
Key words: integrin ¥ migration ¥ cyclic AMP ¥ phos-
phodiesterase ¥ cytoskeleton
C
 
arcinoma
 
 invasion is a complex process that in-
volves directed migration and localized proteolysis
(24). Although the mechanistic basis of invasion
had been elusive, recent advances in molecular cell biol-
ogy have facilitated a much more rigorous analysis of this
important and critical component of cancer progression.
In particular, insight into the function and regulation of
cell adhesion receptors, as well as proteases, has fueled
significant progress in our understanding of the invasive
process. Studies aimed at defining specific signal transduc-
tion pathways that determine the behavior of invasive car-
cinoma cells are also contributing to an uncovering of the
molecular basis of invasion.
Recent work by our group and others has implicated a
key role for the 
 
a
 
6
 
b
 
4 integrin in carcinoma invasion (3, 10,
32, 35, 40, 47). This integrin, which is a receptor for the
laminins, is essential for the organization and maintenance
of epithelial structure. In many epithelia, 
 
a
 
6
 
b
 
4 mediates
the formation of stable adhesive structures termed hemi-
desmosomes that link the intermediate filament cytoskele-
ton with the extracellular matrix (2, 12). The importance
of this integrin in epithelial structure has been reinforced
by the generation of 
 
b
 
4-nullizygous mice that exhibit gross
alterations in epithelial morphology and anchorage to the
basement membrane (9, 46). In contrast to its function in
normal epithelia, 
 
a
 
6
 
b
 
4 can stimulate carcinoma migration
and invasion through its ability to interact with the actin
cytoskeleton and mediate the formation and stabilization
of lamellae (32). This dynamic function of 
 
a
 
6
 
b
 
4 in enhanc-
ing the migration of invasive carcinoma cells is quite dis-
tinct from its role in maintaining stable adhesive contacts
in normal epithelia by associating with intermediate fila-
ments. In fact, we have established that the ability of 
 
a
 
6
 
b
 
4
to stimulate carcinoma migration and invasion depends
upon its preferential activation of a phosphoinositide 3-OH
kinase (PI3-K)
 
1
 
/Rac signaling pathway that we (40) and
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1. 
 
Abbreviations used in this paper:
 
 [cAMP]
 
i
 
, intracellular cyclic AMP con-
centration; DIC, differential—interference contrast; Gi, inhibitory type G
protein; IBMX, isobutylmethylxanthine; LPA, lysophosphatidic acid;
PDE; phosphodiesterase; PI3-K, phosphoinositide 3-OH kinase.
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others (18) have shown is necessary for invasion. In es-
sence, our studies have defined an integrin-mediated
mechanism of carcinoma invasion that involves the stimu-
lation of carcinoma migration by the dynamic association
of 
 
a
 
6
 
b
 
4 with F-actin and the activation of a specific signal-
ing pathway by this integrin.
Although we have established the involvement of 
 
a
 
6
 
b
 
4
in the migration of invasive carcinoma cells, the nature of
this migration has not been well defined. Moreover, sig-
naling pathways distinct from PI3-K/Rac that are also reg-
ulated by 
 
a
 
6
 
b
 
4 are likely to contribute to carcinoma mi-
gration. For these reasons, we sought to examine the
migration mediated by 
 
a
 
6
 
b
 
4 in more detail and to identify
other signaling pathways regulated by this integrin that
contribute to migration. The results obtained indicate that
 
a
 
6
 
b
 
4 stimulates the chemotactic migration of invasive car-
cinoma cells but that it has no influence on their haptotac-
tic migration. Importantly, we demonstrate that the ability
of 
 
a
 
6
 
b
 
4 to suppress the intracellular cAMP concentration
([cAMP]
 
i
 
) by activating a cAMP-specific phosphodiester-
ase (PDE) is essential for its enhancement of lamellae for-
mation and chemotactic migration. Although PI3-K and
cAMP-specific PDE activities are required for lamellae for-
mation and chemotactic migration, we conclude that they
are components of distinct signaling pathways.
 
Materials and Methods
 
Cell Culture and Antibodies
 
We used stable subclones of MDA-MB-435 human breast carcinoma cells
that had been transfected with either the expression vector alone (mock
transfectants), a full-length 
 
b
 
4 cDNA (MDA/
 
b
 
4 transfectants), or a mu-
tated 
 
b
 
4 cDNA that lacked the entire cytoplasmic domain with the excep-
tion of four amino acids distal to the transmembrane sequence (MDA/
 
b
 
4-
 
D
 
CYT). The characterization of these transfectants has been described
previously (38, 40). Both the 
 
b
 
4 transfectants and the 
 
b
 
4-
 
D
 
CYT transfec-
tants expressed the 
 
a
 
6
 
b
 
4 heterodimer on the cell surface as assessed by
FACS
 
¤
 
 analysis and immunoprecipitation of surface-labeled extracts (40).
The surface expression of 
 
a
 
6
 
b
 
4 in these transfectants was comparable
to the expression seen in other breast carcinoma cell lines that express
this integrin endogenously such as MDA-MB-231 cells (Shaw, L.M., un-
published observation). All MDA-MB-435 cells were cultured in Dul-
beccoÕs modified EagleÕs medium (DME) with 10% fetal calf serum plus
1% 
 
l
 
-glutamine, 1% penicillin, and 1% streptomycin (GIBCO BRL,
Gaithersburg, MD). Clone A cells, originally isolated from a human,
poorly differentiated colon adenocarcinoma (7) and were cultured in
RPMI 1640 medium containing 10% fetal calf serum plus 1% 
 
l
 
-glutamine,
1% penicillin, and 1% streptomycin.
NIH-3T3 cells were cultured in DME containing 10% newborn calf se-
rum plus 1% 
 
l
 
-glutamine, 1% penicillin, and 1% streptomycin. NIH-3T3
conditioned medium was prepared from normal culture medium incu-
bated with cells for 2 d before harvest with cellular debris removed by cen-
trifugation.
The following function blocking, integrin-specific monoclonal antibod-
ies (mAb) were used: mAb 13 (mouse anti-
 
b
 
1; S. Akiyama, National Insti-
tutes of Health, Research Triangle Park, NC), G0H3 (rat anti-
 
a
 
6; Immu-
notech, Westbrook, ME) and 2B7 (mouse anti-
 
a
 
6, prepared by our
laboratory [39]). Non-specific mouse IgG was purchased from Sigma
Chemical Co. (St. Louis, MO).
 
Migration and Invasion Assays
 
Cells were harvested using trypsin, rinsed three times with serum-free
DME containing 250 
 
m
 
g/ml heat-inactivated BSA (DME/BSA), and then
resuspended in DME/BSA. For migration assays, the lower surface of the
membrane in each Transwell chamber (6.5-mm-diam, 8 
 
m
 
m pore size;
Costar, Cambridge, MA) was coated for 30 min with either 15 
 
m
 
g/ml lami-
nin-1 purified from Englebreth-Holm-Swarm tumor (19), 15 
 
m
 
g/ml col-
lagen I (Vitrogen
 
¤
 
; Collagen Biomaterials, Palo Alto, CA), or NIH-3T3
conditioned medium. For chemotaxis assays, either NIH-3T3 conditioned
medium or lysophosphatidic acid (LPA) was added to the lower chamber.
For haptotaxis assays, DME/BSA was added to the lower chamber. Cells
(5 
 
3 
 
10
 
4
 
) suspended in DME/BSA were added to the upper chamber. Af-
ter incubating for 4 h at 37
 
8
 
C, nonmigrating cells were removed from the
upper chamber with a cotton swab and cells that had migrated to the
lower surface of the membrane were fixed with 100% methanol and
stained with 0.2% (wt/vol) crystal violet in 2% ethanol. Migration was
quantified by counting cells per square millimeter using bright-field optics.
For antibody inhibition experiments, cells were incubated with 20 
 
m
 
g/ml
of antibody for 30 min and then added to the Transwell chambers. The ef-
fects of pertussis toxin, IBMX (Calbiochem-Novabiochem, La Jolla, CA),
forskolin, and rolipram (Sigma Chemical Co.) on migration were assessed
by preincubating the cells with these reagents for 30 min before assay and
including them in the assay medium at the concentrations noted in the fig-
ure legends.
Invasion assays were performed as described previously (40). In brief,
10 
 
m
 
g of Matrigel (Collaborative Research, Bedford, MA) was diluted
with cold water and dried onto each Transwell filter. The Matrigel was
reconstituted with DME for 1 h before its use in the assays. Cells were
prepared as above and then added to the upper chamber of each well.
NIH-3T3 conditioned medium was added to the lower chamber. Cells
were allowed to invade for 4 h and then cells that had invaded were
stained and quantified as described above.
 
cAMP Assays
 
Culture dishes (35-mm) were coated overnight with 20 
 
m
 
g/ml of collagen I
in PBS and then blocked with serum-free RPMI containing 250 
 
m
 
g/ml
BSA (RPMI/BSA). Cells (1.5 
 
3 
 
10
 
6
 
) were then plated for 2 h and har-
vested by quickly removing the medium and extracting them directly with
80% (vol/vol) ethanol. Cell extracts were collected, cleared by centrifuga-
tion in a microcentrifuge for 10 min, dried in a SpeedVac (Savant Instru-
ments, Farmingdale, NY) for 1.5 h, and then resuspended in 50 mM
phosphate buffer, pH 6.2. The intracellular cAMP concentration was
quantified using a cAMP enzyme-linked immunoabsorption assay (cAMP
EIA; Cayman Biochemicals, Ann Arbor, MI) following the manufac-
turerÕs recommendation using nonacetylated cAMP as a standard and
acetylcholine esterase-linked cAMP as a competitor. Values were cor-
rected for cell number as determined from replicate plates. In some exper-
iments, either 50 
 
m
 
M forskolin alone or forskolin plus 1 mM IBMX was
added to cells 15 min before harvesting. To determine the cAMP content
of cells under normal culture conditions, cells were plated in 35-mm dishes
in DME plus 10% FCS, incubated for 18 h, and then processed as de-
scribed above.
 
Phosphodiesterase Assays
 
cAMP PDE assays were performed according to the protocol of Sette et
al. (37). In brief, cells were plated onto collagen I coated dishes as de-
scribed for cAMP assays. Cells were then scraped from the dishes in a hy-
potonic lysis buffer (PDE lysis buffer: 20 mM Tris-HCl, pH 8.0, 1 mM
EDTA, 0.2 mM EGTA, 50 mM sodium fluoride, 10 mM sodium pyro-
phosphate, 0.5 
 
m
 
g/ml leupeptin, 0.7 
 
m
 
g/ml pepstatin, 4 
 
m
 
g/ml aprotinin,
and 2 mM PMSF) and then sonicated. Cellular debris was removed by
centrifugation and the supernatants were assayed immediately for PDE
activity. PDE activity of cell extracts (2—4 
 
m
 
g protein) was assayed in
cAMP PDE assay buffer (20 mM Tris-HCl, pH 8.0, 10 mM MgCl
 
2
 
, 1.25
mM 
 
b
 
-mercaptoethanol, 0.14 mg/ml BSA, 1 
 
m
 
M cAMP, and 0.2 
 
m
 
Ci [
 
3
 
H]
cAMP) for 10 min at 34
 
8
 
C. The reaction was stopped by adding 40 mM
Tris, pH 7.5, containing 10 mM EDTA and heating for 2 min at 100
 
8
 
C.
The reaction products were then digested with 50 
 
m
 
g 
 
Crotalus atrox
 
 snake
venom (Sigma Chemical Co.) for 30 min at 34
 
8
 
C, separated from substrate
using SpinZyme acidic alumina devices (Pierce Chemical Co., Rockford,
IL), and quantified using a scintillation counter (Wallace, Gaithersburg,
MD). Values were corrected for protein content and are reported as pmol
cAMP hydrolyzed/min per milligram of protein. Protein content of cell
extracts was determined using the Bio-Rad protein reagent (Hercules,
CA) with BSA as a protein standard. Where noted, cells were incubated
either for 30 min with 50 
 
m
 
M forskolin or 100 nM wortmannin or for 5 min
with 100 nM LPA before harvest. For rolipram inhibition of PDE activ-
ity, 100 nM rolipram was added to cell extracts for 5 min before assaying
for PDE activity.
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Assessment of Lamellae Formation
 
Glass coverslips were coated overnight at 4
 
8
 
C with 20 
 
m
 
g/ml collagen I or
laminin-1 and then blocked with BSA (0.25% in RPMI). The MDA-MB-
435 transfectants were trypsinized and rinsed as described above, and then
plated onto the coverslips for 2 h. As noted, cells were then treated with
either 1 mM IBMX or 0.2% DMSO for 30 min. Subsequently, the cells
were either treated with 100 nM LPA for 5 min or left untreated and then
fixed for 10 min with 4% paraformaldehyde containing 10 mM Pipes, pH
6.8, 2 mM EGTA, 2 mM MgCl
 
2
 
, 7% sucrose, and 100mM KCl. The cover-
slips were rinsed three times with PBS and mounted in glycerol. For the
analysis of clone A cells, the cells were treated with IBMX or DMSO for
30 min, plated on laminin-1—coated coverslips, incubated for 45 min at
37
 
8
 
C, and then fixed. Clone A cells were then rinsed three times with PBS
and incubated with blocking solution containing 1% BSA/5% normal
donkey serum for 30 min. Cells were incubated with 20 
 
m
 
g/ml TRITC-
labeled phalloidin in blocking solution for 30 min. Cells were rinsed four
times with PBS over 30 min and then mounted in glycerol containing 1
 
3
 
PBS, pH 8.5, and 0.1% propylgallate. All cells were imaged with a Nikon
Diaphot 300 inverted microscope (Tokyo, Japan) using either Nomarski
differential—interference contrast (DIC) or phase—contrast optics. Images
were captured with a charge-coupled device camera (Dage-MTI, Michi-
gan City, IN), a frame grabber (Scion, Frederick, MD) and a 7600 Power
Macintosh computer (Apple Computer, Cupertino, CA). Images were an-
alyzed and lamellar area quantified using IPLab Spectrum image analysis
software (Signal Analytics, Vienna, VA) using the criteria for defining
lamellae used previously by our group (32). Lamellae were defined as
broad, flat cellular protrusions rich in F-actin and devoid of membrane-
bound vesicles. The lamellar area of each cell was determined using both
phase contrast optics and FITC-phalloidin staining.
 
Analysis of PDE Expression
 
To determine the relative expression of PDE in the cells used in this
study, cell extracts (40 
 
m
 
g of protein) were resolved by SDS-PAGE (8%),
transferred to nitrocellulose, and then immunoblotted with PDE4-specific
antibodies provided by M. Conti (Stanford University, Stanford, CA) (15).
Immune complexes were detected with horseradish peroxidase-conju-
gated secondary antibodies and visualized using SuperSignal chemilumi-
nescent substrate (Pierce Chemical Co.).
 
Analysis of PI3-K Activation
 
The activation of PI3-K by the integrin 
 
a
 
6
 
b
 
4 was assessed as described
previously (40). In brief, cells were trypsinized and rinsed as above, resus-
pended in RPMI/BSA at a concentration of 2 
 
3 
 
10
 
6
 
 cells/ml and incubated
for 30 min with integrin-specific antibodies or in buffer alone. Either
IBMX (1 mM), forskolin (50 
 
m
 
M) or DMSO (0.2%) was added for 10 min
before plating the cells onto tissue culture dishes coated with goat anti—rat
IgG Ab. After incubation for 30 min at 37
 
8
 
C in the presence of IBMX, for-
skolin, or DMSO, the cells were washed twice with cold PBS and solubi-
lized at 4
 
8
 
C for 10 min with 20 mM Tris, pH 7.4, 137 mM NaCl, 1% NP-40,
10% glycerol, 1 mM sodium orthovanadate, 2 mM PMSF, and 5 
 
m
 
g/ml of
aprotinin, pepstatin, and leupeptin. Equivalent amounts of protein from
each extract were incubated for 3 h at 4
 
8
 
C with the antiphosphotyrosine
mAb, 4G10 (Upstate Biotechnology, Lake Placid, NY) and protein A—Seph-
arose (Pharmacia Biotech, Piscataway, NJ). The Sepharose beads were
washed twice with lysis buffer then twice with 10 mM Hepes, pH 7.0, and
0.1 mM EGTA. Beads were then resuspended with kinase buffer plus 100
 
m
 
M ATP, 25 
 
m
 
M MgCl
 
2
 
, 10 
 
m
 
Ci [
 
g
 
-
 
32
 
P]ATP, and 10 
 
m
 
l sonicated brain lip-
ids and incubated for 10 min at room temperature. The reaction was
stopped using 60 ml 2N HCl and 160 ml chloroform/methanol (1:1). Lipids
were resolved using potassium oxalate-coated thin layer chromatography
plates.
Results
Expression of the a6b4 Integrin in MDA-MB-435 Cells 
Enhances Their Chemotactic Migration
The possibility that expression of the a6b4 integrin influ-
enced the rate of either haptotactic or chemotactic migra-
tion was assessed. For this purpose, stable transfectants of
MDA-MB-435 cells were used that expressed either the
a6b4 integrin (MDA/b4) or a deletion mutant of a6b4
(MDA/b4-DCYT) that retains only four amino acids of
the b4 cytoplasmic domain, immediately proximal to the
Figure 1. Expression of the a6b4 integrin in
MDA-MB-435 carcinoma cells stimulates
chemotaxis but not haptotaxis. The migration of
the MDA/b4 (5B3 and 3A7) MDA/b4-DCYT
(D3C12, D1E10), and MDA/mock (6D2 and
6D7) transfectants toward laminin-1 (haptotaxis;
A), 3T3 conditioned medium (chemotaxis; B), or
LPA (chemotaxis; C and D) was assessed using a
modified Boyden chamber. The lower surfaces of
Transwell membranes were coated with either
laminin-1 (A), conditioned medium (B), or col-
lagen I (C and D), and then either BSA (A) 3T3
conditioned medium (B) or LPA (C and D) was
added to the lower chambers. Cells (105 [A and
B] or 5 3 104 [C and D]) were placed in the up-
per chambers. After 4 h at 378C, cells that did not
migrate were removed from the upper chamber
with a cotton swab and cells on the opposite side
of the membrane were fixed, stained, and quanti-
fied manually as described in the Materials and
Methods. (A) Haptotaxis toward laminin-1; (B)
chemotaxis toward NIH-3T3 conditioned me-
dium; (C) dose response of MDA-MB-435 sub-
clones 5B3 (b4 transfected; solid circles) and 6D7
(mock transfected; open squares) chemotaxis to-
ward LPA; (D) Chemotaxis toward 100 nM
LPA. Data are reported as fold increases over
haptotactic migration on collagen I in the ab-
sence of LPA. Data (all panels) are shown as
mean 6 standard deviation from triplicate deter-
minations.
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transmembrane domain (40). As shown in Fig. 1 A, sub-
clones of the MDA/b4 transfectants (5B3 and 3A7) exhib-
ited a rate of haptotactic migration toward laminin-1 that
was slightly lower than the rate observed for subclones of
the mock transfectants (6D7 and 6D2). In marked con-
trast, expression of a6b4 induced a substantial increase in
the rate of chemotaxis of these cells towards conditioned
medium from NIH-3T3 cells (Fig. 1 B). The rate of chemo-
taxis of the MDA/b4 transfectants (5B3 and 3A7) was 15—
20-fold greater than that of the mock transfectants (6D7
and 6D2) over a 4-h time period. These data indicate that
expression of a6b4 potentiates chemotactic migration of
MDA-MB-435 cells without substantially altering their
rate of haptotaxis.
To identify specific factors that could cooperate with
a6b4 to promote chemotaxis of MDA-MB-435 cells, we
tested several growth factors known to have chemotactic
potential including epidermal growth factor, basic fibro-
blast growth factor, hepatocyte growth factor/scatter fac-
tor, insulin-like growth factor type I, transforming growth
factor a and b, platelet-derived growth factor (AA and
BB), somatostatin, thrombin, and LPA. Of these factors,
only LPA was able to mimic the chemotactic effects of
NIH-3T3 cell conditioned medium on the MDA-MB-435
transfectants (Fig. 1 C and data not shown). LPA stimu-
lated the chemotaxis of MDA-MB-435 cells in a dose de-
pendent manner with maximal stimulation observed at
100 nM. Of note, LPA stimulation of chemotaxis was five-
to sevenfold greater in the MDA/b4 transfectants than in
the mock transfectants. Subclones of the MDA/b4-DCYT
transfectants (D3C12 and D1E10) exhibited a rate of che-
motaxis that was similar to the mock transfectants (Fig. 1
D), indicating that the b4 cytoplasmic domain is critical for
mediating the increased chemotaxis seen in the MDA/b4
transfectants.
The increased chemotaxis observed for the MDA/b4
transfectants in response to LPA was evident on both col-
lagen I (Fig. 1, C and D) and laminin-1 (data not shown),
indicating that a6b4-enhanced migration is independent
of the matrix protein used for traction. This possibility was
examined further by preincubating the MDA/b4 transfec-
tants with function-blocking mAbs before their use in the
chemotaxis assays. As shown in Fig. 2 A, inhibition of a6
integrin function with the mAb 2B7 did not block the
chemotaxis of the MDA/b4 transfectants on collagen I to-
wards LPA. However, this mAb inhibited the haptotaxis
of MDA-MB-435 cells toward a laminin-1 gradient (Fig. 2
B), a process that is dependent on the a6b1 integrin (38).
Chemotaxis toward LPA was inhibited completely, how-
ever, by preincubating the cells with the b1 integrin-spe-
cific mAb 13 (Fig. 2 A). Collectively, these data indicate
that the stimulation of chemotaxis by expression of a6b4
can be independent of the adhesive functions of a6b4, and
that the adhesive interactions required for a6b4-enhanced
chemotaxis on collagen I are mediated through b1 inte-
grins.
Expression of the a6b4 Integrin Is Required for the 
Formation of Lamellae in Response to LPA
Chemotactic migration frequently involves the formation
of broad sheets of polymerized actin at the leading edge of
the cell termed lamellae (27). To determine if expression
of the a6b4 integrin influenced the formation of such mo-
tile structures, we analyzed the morphology of the MDA-
MB-435 transfectants plated on collagen I (Fig. 3). Promi-
nent lamellae were not evident in the mock transfectants
and treatment with 100 nM LPA did not stimulate a signif-
icant increase in lamellar area (Fig. 3, C and D). The
MDA/b4 transfectants exhibited a similar morphology to
that of the mock transfectants when plated on collagen I
(Fig. 3, compare A with C) or laminin-1 (data not shown).
Within minutes after LPA treatment, however, the MDA/
b4 transfectants formed large, ruffling lamellae (Fig. 3 C).
Quantification of these cells by digital image analysis indi-
cated that LPA stimulated a dramatic increase in the
lamellar area of the two subclones of the MDA/b4 trans-
fectants (Fig. 3 D). In contrast, no increase in the lamellar
area of the mock transfectants in response to LPA was de-
tected by this analysis (Fig. 3 D).
Pharmacological Evidence for the Involvement of cAMP 
in Chemotaxis
LPA is a bioactive phospholipid that can mediate its ef-
fects on cells through a receptor linked to heterotrimeric
G proteins, including inhibitory type G (Gi) proteins (29).
To assess the possible involvement of a Gi protein in
a6b4-enhanced chemotaxis, we used pertussis toxin, which
inactivates heterotrimeric Gi-proteins by ADP ribosyla-
tion (31). The LPA-stimulated chemotaxis of both the
MDA/b4 and mock transfectants was inhibited by pertus-
sis toxin with maximal inhibition observed at 100 ng/ml
(data not shown). These data suggested that the a6b4 inte-
grin enhances chemotaxis that is mediated through pertus-
sis toxin-sensitive, Gi-linked receptors. Gi proteins are
known to inhibit certain classes of adenyl cyclases and thus
limit cAMP production (45). For this reason, we analyzed
the impact of stimulating cAMP production on chemotaxis
Figure 2. Inhibition of a6b4-stimulated migration by integrin-
specific antibodies. MDA/b4 (5B3; A, gray bars) or mock trans-
fectants (6D7; B, stippled bars) were incubated with the indicated
function blocking mAbs for 30 min before their use in a chemo-
taxis assay using 100 nM LPA on collagen I (A) or a haptotaxis
assay on laminin-1—coated wells (B) as described in Fig. 1. Non-
specific mouse IgG was used as a negative control. Data are re-
ported as the percentage of migration observed for the IgG con-
trol 6 standard deviation from triplicate determinations.
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using forskolin. Although forskolin inhibited LPA-stimu-
lated chemotaxis, the MDA/b4 and mock transfectants
differed significantly in their response to this activator of
adenyl cyclases. LPA-stimulated chemotaxis of the mock
transfectants was inhibited to basal levels by 50 mM for-
skolin (Fig. 4 A). At this concentration of forskolin, the in-
hibition of chemotaxis of the MDA/b4 transfectants was
only 50% and higher concentrations of forskolin (100 mM)
did not abrogate chemotaxis of these cells (Fig. 4 A). In-
terestingly, treatment of the MDA/b4 or mock transfec-
tants with forskolin did not inhibit haptotactic migration
on laminin-1 (Fig. 4 B). These data indicate that a cAMP-
sensitive pathway plays a key role in LPA-stimulated
chemotaxis of MDA-MB-435 cells and they suggest that
the a6b4 integrin may regulate this pathway.
Expression of the a6b4 Integrin in MDA-MB-435 Cells 
Influences cAMP Metabolism
To determine if a6b4 expression influences the [cAMP]i,
the [cAMP]i was determined in extracts obtained from
subconfluent cultures of MDA/mock, b4, and b4-DCYT
transfectants using a cAMP enzyme-linked immunoab-
sorption assay. As shown in Fig. 5 A, the MDA/b4 trans-
fectants had a 30% lower [cAMP]i (2.7 pmol cAMP per
106 cells) than either the mock (3.7 pmol cAMP per 106
cells) or b4-DCYT transfectants (3.8 pmol cAMP per 106
cells). This difference was statistically significant (P ,
0.001). Of note, neither clustering of a6b4 using the 2B7
mAb and an appropriate secondary Ab nor LPA treat-
ment reduced cAMP levels further (data not shown).
The observation that the MDA/b4 transfectants were
more resistant to forskolin inhibition of chemotaxis than
the mock transfectants (Fig. 4) suggested that these two
populations of cells differ in their ability to metabolize the
cAMP generated in response to forskolin stimulation. This
possibility was examined by determining the [cAMP]i in
forskolin-treated cells. As shown in Fig. 5 B, the MDA/b4
transfectants exhibited a 30% lower [cAMP]i than the mock
transfectants when plated on collagen I. With forskolin
stimulation, a 2.5-fold greater accumulation of cAMP was
observed in the mock transfectants (6.6 pmol per 106 cells)
compared with the b4 transfectants (2.6 pmol per 106
cells). When the forskolin-treated cells were also treated
with the PDE inhibitor, IBMX, to prevent breakdown of
cAMP, the MDA/b4 transfectants exhibited a [cAMP]i
comparable to the mock transfectants (120 6 11 versus
104 6 18 pmol per 106 cells, respectively; Fig. 5 C). To-
gether, these data suggest that expression of a6b4 integrin
suppresses the [cAMP]i by increasing PDE activity.
To establish more directly that expression of the a6b4
integrin can regulate cAMP-dependent PDE activity, the
activity of this enzyme was assayed in cell extracts ob-
tained from the MDA/mock and b4 transfectants. As
shown in Fig. 6 A, the MDA/b4 transfectants exhibited a
significantly higher rate of PDE activity than the mock
transfected cells. Moreover, the PDE activity of the MDA/
b4 transfectants was markedly increased (51% for 5B3
and 45% for 3A7) in response to forskolin stimulation
compared with the mock transfectants (29% for 6D7; Fig.
6 A). The difference in PDE activity between the MDA/b4
and mock transfectants was eliminated by rolipram, a type
IV PDE-specific (PDE 4) inhibitor (Fig. 6 B). These data
indicate that a cAMP-dependent PDE 4 activity is influ-
enced by a6b4 expression in MDA-MB-435 cells. Also,
this activity is likely responsible for the observed decrease
in [cAMP]i and the resistance to forskolin-mediated inhi-
bition of LPA chemotaxis observed in the MDA/b4 trans-
fectants.
To examine the possibility that the MDA/b4 and mock
Figure 3. The a6b4 integrin
is required for the LPA-
dependent formation of
lamellae in MDA-MB-435
cells. MDA/b4 (A and B) and
mock transfectants (C) were
plated onto coverslips that
had been coated with 20 mg/
ml collagen I. Cells were al-
lowed to adhere for 2 h at
378C and then treated with
LPA for 5 min. (B and C) or
left untreated (A). The cells
were visualized using Nomar-
ski DIC optics. Note the large
lamellae that are formed in
response to LPA stimulation
of the MDA/b4 transfectants.
(D) The effect of LPA on
lamellar area was quantified
using IPLab Spectrum imag-
ing software. Data are shown
as mean lamellar area 6 stan-
dard error in which n . 20.
Bar, 10 mm.
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transfectants differed in their level of PDE expression, we
assessed PDE 4 expression in these cells using antibodies
specific for the various PDE 4 variants (15). The predomi-
nant PDE 4 variant expressed in MDA-MB-435 cells is
PDE 4B based on results obtained with antibodies specific
for PDE 4A, 4B and 4D (data not shown). Importantly,
the expression of PDE 4B did not differ significantly be-
tween the MDA/b4 and mock transfectants (Fig. 6 C).
These data indicate that the increased PDE activity ob-
served in the MDA/b4 transfectants is not the result of in-
creased PDE expression.
PDE Activity Is Necessary for Chemotaxis, Invasion, 
and Lamellae Formation
The importance of PDE for chemotactic migration was ex-
amined by treating the MDA/mock and b4 transfectants
with IBMX before their use in the chemotaxis assay. As
shown in Fig. 7 A, IBMX inhibited LPA-stimulated chemo-
taxis with maximal inhibition observed at 1 mM. Similar
results were obtained with the cAMP-specific PDE inhibi-
Figure 4. Forskolin stimulation of adenyl cyclase inhibits LPA-
mediated chemotaxis differentially in the MDA/b4 and mock
transfectants. (A) MDA/b4 transfectants (5B3; solid circles) or
mock transfectants (6D7; open squares) were treated with the in-
dicated concentration of forskolin for 30 min before their addi-
tion to the upper wells of the Transwell chambers. Cells were as-
sayed for LPA-mediated chemotaxis on collagen I as described in
Fig. 1. The dashed line depicts the basal level of migration of both
subclones in the absence of LPA. (B) In a separate experiment,
the same cells were treated with forskolin for 30 min before as-
saying for LPA chemotaxis (solid symbols) or laminin haptotaxis
(open symbols). Data are reported as the percent migration of
cells not treated with forskolin 6 standard deviation of triplicate
determinations.
Figure 5. Intracellular cAMP content of the MDA-MB-435
transfectants. The MDA/b4 (3A7, 5B3), MDA/b4-DCYT
(D3C12, D1E10) and MDA/mock transfectants (6D2, 6D7) were
plated in DME containing 10% FCS. After 18 h, cells were har-
vested and cAMP content was measured using a cAMP EIA pro-
tocol as described in Materials and Methods. Data shown repre-
sent the mean of 10 sample determinations 6 standard error. The
difference in the [cAMP]i between the MDA/b4 and the mock
transfectants is significant (P , 0.001; asterisk), but the difference
between the mock and the b4-DCYT transfectants is not signifi-
cant (P 5 0.2). (B and C) Differential effects of forskolin stimula-
tion on the [cAMP]i in the MDA/b4 and mock transfectants. The
[cAMP]i was assayed in the 5B3 (solid bars) and 6D7 (stippled
bars) clones plated on collagen I and treated for 15 min with ei-
ther 50 mM forskolin (B) or forskolin and 1 mM IBMX (C). Note
that the MDA/b4 transfectants (5B3) are more resistant to a for-
skolin-stimulated increase in [cAMP]i than the mock transfec-
tants (6D7). The inhibition of PDE activity with IBMX shown in
C reveals that a6b4 expression results in an increase in PDE ac-
tivity and not a decrease in cAMP synthesis. Data shown are the
mean values 6 standard error obtained from multiple experi-
ments.
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tor, rolipram (data not shown). We also examined the in-
volvement of PDE in carcinoma invasion by treating cells
with IBMX before their use in a standard Matrigel inva-
sion assay. A substantial inhibition of invasion was ob-
served in the presence of IBMX in comparison to the sol-
vent control (Fig. 7 B).
The necessity of cAMP-specific PDE activity in the for-
mation of lamellae was also assessed. IBMX had no effect
on the morphology of the MDA/b4 transfectants in the ab-
sence of LPA (Fig. 8, compare A with B). However,
IBMX-treated cells were unable to form the large, ruffling
lamellae in response to LPA stimulation in comparison to
untreated cells (Fig. 8, compare C with D). Quantitative
analysis of these cell populations revealed that inhibition
of PDE activity resulted in an approximate fourfold reduc-
tion in the lamellar area of LPA-stimulated MDA/b4
transfectants (Fig. 8 E).
Recently, we reported that a6b4 is necessary for the for-
mation and stabilization of lamellae in clone A colon car-
cinoma cells plated on laminin-1 (32). If PDE activity is
needed for lamellae formation as indicated by the above
results, IBMX should inhibit the formation of lamellae in
clone A cells. To test this possibility, clone A cells were
treated with IBMX or a solvent control and then plated
onto laminin-1 for 45 min. The control cells formed large
fan-shaped lamellae enriched in F-actin when plated on
laminin-1 (Fig. 9, A and B) as we reported previously (32).
In contrast, IBMX-treated cells formed small, immature
lamellae with a marked reduction in F-actin content (Fig.
9, C and D). Quantitative analysis of these images re-
Figure 6. Assay of cAMP-specific PDE activity. (A) MDA/b4
(3A7 and 5B3) or mock transfectants (6D7) plated on collagen I
were treated with 50 mM forskolin or 100 nM LPA as noted. Cells
were harvested and the cytosolic fraction was assayed for PDE
activity as described in Materials and Methods. The PDE activity
of the MDA/b4 transfectants was compared with the MDA/mock
transfectants for statistical significance: *, P , 0.002;  , P , 0.01.
(B) Extracts from cells treated as in A were incubated with
100 mM rolipram before assaying for PDE activity to determine
how much of the activity in A constitutes cAMP-specific PDE
(PDE 4). Data shown are mean 6 standard error of four separate
determinations (A and B). ns, not significant; e, P 5 0.02. (C)
Relative expression of PDE 4B in the MDA-MB-435 transfec-
tants. Extracts (40 mg protein) obtained from the MDA/b4 (3A7
and 5B3) and mock (6D2 and 6D7) transfectants, as well as puri-
fied PDE 4 proteins (short form of variants A, B, and D; 10 ng
each; provided by M. Conti) were resolved by SDS-PAGE and
immunoblotted with a PDE 4B-specific Ab. Arrows, long and
short forms of PDE 4B.
Figure 7. cAMP specific-PDE activity is required for the chemo-
tactic migration and invasion of MDA-MB-435 cells. The MDA/
b4 (5B3; squares) or mock transfectants (6D7; circles) were
treated with varying concentrations (A) or 1 mM (B) IBMX for
30 min before their use in either an LPA chemotaxis assay (A) or
a Matrigel chemoinvasion assay (B). Data shown represent mean
values 6 standard deviation of triplicate determinations.
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vealed that IBMX reduced the total lamellar area of clone
A cells on laminin-1 by z75% (629 6 74 mm2 for control
versus 164 6 24mm2 with IBMX). Interestingly, inhibition
of PDE activity had no effect on the attachment or spread-
ing of clone A cells on laminin-1 (Fig. 9).
cAMP Metabolism and PI3-K Signaling Are Not 
Directly Linked in MDA-MB-435 Cells 
A possible relationship between cAMP metabolism and
PI3-K signaling is of interest given our recent finding that
a6b4 stimulates the preferential activation of PI3-K and
that this activity is required for invasion and the formation
of lamellae (40). To determine if PI3-K activity is required
for the cAMP-specific PDE activity we observed in the
MDA/b4 transfectants, these cells were incubated in the
presence of wortmannin, a specific inhibitor of PI3-K, be-
fore extraction and assay of PDE activity. As shown in Fig.
10 A, wortmannin had no effect on PDE activity in these
cells and it did not inhibit the marked induction of PDE
activity that we had observed in response to forskolin
stimulation. The possibility also existed that cAMP influ-
ences the a6b4-mediated activation of PI3-K. To address
this issue, we used the a6-specific mAb G0H3 to cluster a6
integrins on the MDA/b4 transfectants in the presence of
the PDE inhibitor IBMX and forskolin. As shown in Fig.
10 B, mAb-mediated clustering of a6b4 in MDA/b4 trans-
fectants activated PI3-K markedly compared with cells
maintained in suspension, in agreement with our previous
results (40). However, treatment of MDA/b4 transfectants
with either IBMX or forskolin did not inhibit a6b4-medi-
ated activation of PI3-K (Fig. 10 B). In fact, no inhibition
of PI3-K was observed when both of these inhibitors were
used in combination, a treatment that increases the [cAMP]i
from 4 to 120 pmoles per 106 cells (Fig. 5).
Discussion
Recently, we established that the a6b4 integrin promotes
carcinoma invasion (3, 32, 40). In the current study, we ex-
tend this observation by demonstrating that a major func-
tion of a6b4 is to stimulate the chemotactic migration of
carcinoma cells, a function that is essential for invasion.
This function is consistent with our previous finding that
a6b4 is involved in the formation and stabilization of
lamellae and filopodia (32). Importantly, the data pre-
sented here also provide evidence that a6b4 stimulates
chemotaxis and lamellae formation by regulating the
[cAMP]i by a mechanism that involves activation of a ro-
lipram-sensitive, cAMP-specific PDE. Our finding that el-
evated [cAMP]i inhibits the formation of lamellae, chemo-
tactic migration, and invasion is in agreement with recent
studies indicating that cAMP can function to inhibit or
ÒgateÓ specific signaling pathways (14, 16, 23). Further-
Figure 8. cAMP specific-PDE activity is required for LPA-depen-
dent formation of lamellae in the MDA/b4 transfectants. The
MDA/b4 transfectants (5B3) were plated on collagen I—coated
coverslips. After 2 h, the cells were either left untreated (A and
C) or treated with 1mM IBMX (B and D) for 30 min. Subse-
quently, the cells were either left untreated (A and B) or treated
with 100 nM LPA for 5 min (C and D). The cells were then fixed
and visualized using Nomarski DIC optics. (E) The effect of LPA
and IBMX on lamellar area was quantified using IPLab Spectrum
imaging software. Bars represent mean lamellar area 6 standard
error in which n . 20. Of note, IBMX inhibited the LPA-depen-
dent formation of lamellae by 70%.
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more, we show that the cAMP-mediated gate does not in-
fluence haptotaxis thus providing additional evidence that
the signaling events governing chemotaxis and haptotaxis
differ (1, 20). Collectively, our results strengthen the hy-
pothesis that a6b4 promotes carcinoma invasion through
its ability to regulate signaling pathways required for mi-
gration. They also indicate that cAMP metabolism is likely
to be an important factor in the regulation of carcinoma
invasion and progression.
Although integrins can regulate a number of signaling
pathways (4), their ability to influence cAMP metabolism
has not been studied extensively. An earlier study, how-
ever, did provide evidence that the simultaneous engage-
ment of b2 integrins and tumor necrosis factor (TNF)
receptors decreases the [cAMP]i in neutrophils (30). Inter-
estingly, the reduction in [cAMP]i observed in response to
b2 integrin and TNF receptor engagement in neutrophils
is similar to the level of [cAMP]i suppression that we ob-
served in response to a6b4 expression (z30%). This level
of suppression of the total [cAMP]i is quite impressive
given that localized gradients of [cAMP]i are probably re-
quired to facilitate chemotactic migration, as well as for
other cell functions that are gated by cAMP. For example,
localized gradients of cAMP have been implicated in regu-
lating the direction of growth cone turning (41). It is also
important to note that we observed an inverse correlation
between the [cAMP]i and the rate of chemotaxis (compare
values in Fig. 4 A with Fig. 5 B). This observation rein-
forces the functional significance of a6b4 suppression of
the [cAMP]i.
A novel aspect of our study is the finding that integrins,
and a6b4 in particular, can regulate the activity of a roli-
pram-sensitive, cAMP-specific PDE. This family of PDEs
is defined as type IV PDE (PDE 4) and consists of a num-
ber of structural variants (6). Because all of these variants
hydrolyze cAMP with a Km comparable to the [cAMP]i, it
is thought that tissue-specific expression and the state of
activity of these variants are the major determinants of
their responsiveness to extracellular stimuli (6). Indeed,
the major focus of work in this area has been hormonal
regulation of PDE activity. Regulation of PDE activity can
occur rapidly in response to hormone stimulation through
a mechanism that involves PKA-dependent phosphoryla-
tion of the enzyme (36, 37). In addition, long-term, hor-
monal stimulation can actually increase de novo synthesis
of the cAMP-specific PDEs (6, 43). The data we obtained
suggest that expression of a6b4 does not increase the ex-
pression of PDE 4B, a predominant PDE variant ex-
pressed by MDA-MB-435 cells. For this reason, regulation
of PDE 4 activity by a6b4 expression may occur through a
mechanism that involves PDE phosphorylation. Another
possibility that has been proposed recently is that the sub-
cellular localization of the cAMP-specific PDEs influences
their function and activation (17). The possibility that
a6b4 increases the association of PDE 4 with either the
plasma membrane or cytoskeleton is certainly attractive
and could account, at least in part, for its ability to influ-
ence cAMP metabolism. Interestingly, LPA stimulation
by itself had no effect on either PDE activity or the
[cAMP]i in MDA-MB-435 cells. This observation rein-
forces our hypothesis that a major function of a6b4 is to
release cAMP gating of LPA-stimulated chemotaxis.
In previous studies, we established that an important
function of a6b4 in invasive carcinoma cells is its ability to
stimulate the formation of lamellae (32). This function of
a6b4 is highlighted by the observation in the present study
Figure 9. Lamellae forma-
tion in clone A colon carci-
noma cells requires PDE
activity. Clone A colon carci-
noma cells were either treated
with solvent alone (A and B)
or 1 mM IBMX in solvent (C
and D) and then plated on
laminin-1—coated coverslips.
After 45 min the cells were
fixed and stained for F-actin
using TRITC-phalloidin. (A
and C) Phase—contrast im-
ages; (B and D) fluorescence
images. Bar, 10 mm.
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that LPA was able to induce significant lamellae forma-
tion only in MDA-MB-435 cells that expressed a6b4 (Fig.
3). Importantly, our finding that PDE activity is necessary
for lamellae formation promoted by a6b4 expression im-
plies that a localized suppression of the [cAMP]i plays an
important role in controlling the signaling and cytoskeletal
events that are required for lamellae formation. This hy-
pothesis agrees with studies that have shown an inhibitory
effect of cAMP on the organization of the actin cytoskele-
ton (11, 13, 21, 22). Moreover, the formation of lamellae is
a dynamic process that is linked to the mechanism of cell
migration. Therefore, it is likely that temporal fluxes in the
[cAMP]i regulated by a6b4 contribute to the chemotactic
migration of carcinoma cells.
Of particular relevance to our work, Butcher and col-
leagues (23) reported that cAMP is a negative regulator of
leukocyte migration signaled through the classical chemo-
attractants. In this model, cAMP impedes or gates RhoA-
mediated leukocyte integrin activation and adhesion.
Our results support their conclusion that cAMP inhibits
chemotactic migration. Importantly, we also provide evi-
dence for an integrin-mediated mechanism of regulating
the [cAMP]i to facilitate migration. Our findings support
the work of the Butcher group because LPA is a potent ac-
tivator of Rho (29) and, in fact, we have observed that the
expression of a dominant-negative Rho can inhibit both
LPA-stimulated chemotactic migration and invasion of
MDA-MB-435 cells (OÕConnor, K.L., and A.M. Mercurio,
unpublished observation). Thus, a possibility worth inves-
tigating is that LPA-mediated activation of Rho is gated
by cAMP and that a6b4 releases cAMP gating by increas-
ing cAMP-specific PDE activity and thereby enhances
Rho activation. A likely target of Rho activation is the ac-
tin cytoskeleton (44), which is consistent with the reported
effects of cAMP on the cytoskeleton (11, 13, 21, 22), as
well as our demonstration that cAMP inhibits lamellae
formation. Although Rho has been linked to stress fiber
formation and not lamellae formation in fibroblasts (25),
much less is known about Rho function in epithelial-
derived cells. In fact, our preliminary data suggest that
LPA-induction of lamellae formation in the MDA/b4 trans-
fectants is inhibited by expression of a dominant-negative
Rho. Other integrins, especially the b1 integrins that me-
diate the adhesive interactions required for chemotactic
migration, are another potential target of Rho (25, 34). It
is worth noting in this context that expression of a6b4 has
been shown to alter the function of collagen I—binding in-
tegrins in breast carcinoma cells (42).
The ability of a6b4 to promote lamellae formation and
carcinoma invasion is dependent upon its preferential acti-
vation of a PI3-K and Rac signaling pathway (40). Our
current finding that the release of cAMP gating by a6b4 is
also required for these events raised the issue of a possible
link between cAMP and the PI3-K/Rac pathway. Such a
link was suggested, for example, by the finding that the in-
terleukin-2 dependent activation of PI3-K is inhibited by
cAMP (28). In our experiments, however, pharmacologi-
cal stimulation of cAMP levels had no effect on the ability
of a6b4 to activate PI3-K even under conditions in which
the [cAMP]i increased 30-fold over basal levels. Our data
also indicate that PI3-K probably does not function up-
stream of cAMP-specific PDE because wortmannin did
not inhibit the activity of this enzyme. We conclude from
these findings that PI3-K and cAMP-specific phosphodi-
esterase function in tandem to promote lamellae forma-
tion and chemotactic migration but they are components
of distinct signaling pathways.
An interesting finding in the present study is that the
ability of a6b4 to stimulate chemotactic migration and
suppress the [cAMP]i can be independent of the adhesive
function of this integrin. Although the laminins are the
only known matrix ligands for a6b4 (26), expression of
this integrin also stimulated chemotactic migration on a
collagen I matrix and this migration was not inhibited by
an a6-function blocking mAb. The possibility that the ef-
fects of a6b4 expression on migration result from a de-
Figure 10. (A) Evaluation of PI3-K involvement in PDE activity.
The MDA/b4 transfectants were incubated for 30 min in the
presence of either forskolin or wortmannin, or both in combina-
tion, before assay of PDE activity as described in Materials and
Methods. (B) Evaluation of the cAMP regulation of PI3-K activ-
ity. The MDA/b4 and mock transfectants were incubated in sus-
pension with either forskolin or IBMX or both for 10 min. Subse-
quently, these cells were either maintained in suspension or
incubated with a b4 integrin-specific antibody and allowed to ad-
here to anti-mouse IgG-coated plates or laminin-1—coated plates
for 30 min. Aliquots of cell extracts that contained equivalent
amounts of protein were incubated with the anti-phosphotyrosine
mAb 4G10 and protein A—Sepharose for 3 h. After washing, the
beads were resuspended in kinase buffer and incubated for 10
min at room temperature. The phosphorylated lipids were re-
solved by thin layer chromatography. Arrows, position of the D3-
phosphoinositides.
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crease of a6b1 expression is discounted by the fact that ex-
pression of the a6b4 DCYT integrin had no effect on
either chemotaxis, cAMP levels or PDE activity even
though expression of this mutant integrin eliminates a6b1
expression in these cells (38). The observation that the
ability of a6b4 to promote chemotactic migration can be
independent of its adhesive function is in agreement with
several recent studies by our group and others that have
revealed Ôligand-independentÕ functions for the a6 inte-
grins in carcinoma cells (3, 5, 8). Insight into the possible
mechanism of this phenomenon was provided by a recent
study that demonstrated self-association of the b4 cyto-
plasmic domains, a process that could initiate intracellular
signaling events independently of ligand binding (33). One
important implication of these findings is that the ability of
a6b4 to influence cAMP metabolism and stimulate the
chemotactic migration of carcinoma cells need not be lim-
ited to sites of contact with laminin-containing matrices.
This possibility is supported by the numerous studies that
have implicated a6b4 as a major determinant of carci-
noma invasion and progression (10, 35, 47).
In summary, we have demonstrated that the a6b4 in-
tegrin can stimulate lamellae formation and chemotactic
migration of invasive carcinoma cells by increasing the ac-
tivity of a rolipram-sensitive cAMP specific-PDE and low-
ering the [cAMP]i. This cAMP specific-PDE functions in
tandem with a PI3-K/Rac pathway, that is also regulated
by a6b4, and is required for carcinoma invasion and lamel-
lae formation. The essence of our findings is that the a6b4
integrin stimulates the chemotactic migration of carci-
noma cells through its ability to influence key signaling
events that underlie this critical component of carcinoma
invasion.
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